يعرض 1 - 10 نتائج من 14 نتيجة بحث عن '"Coronavirus Infections virology"', وقت الاستعلام: 1.65s تنقيح النتائج
  1. 1

    المساهمون: Médicaments et Technologies pour la Santé (MTS), Université Paris-Saclay-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Virulence bactérienne et maladies infectieuses (VBMI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Salvy-Córdoba, Nathalie, ANR-17-CE18-0023,Phylopeptidomics,Identification rapide de bactéries pathogènes et résistances aux antibiotiques(2017)

    المصدر: Journal of Proteome Research
    Journal of Proteome Research, American Chemical Society, 2020, 19 (11), pp.4407-4416. ⟨10.1021/acs.jproteome.0c00535⟩
    Journal of Proteome Research, 2020, 19 (11), pp.4407-4416. ⟨10.1021/acs.jproteome.0c00535⟩

    مصطلحات موضوعية: 0301 basic medicine, Proteomics, MESH: Coronavirus Infections* / virology, MESH: Pneumonia, Viral* / virology, Shotgun, MESH: Coronavirus Infections* / diagnosis, MESH: Nasopharynx / virology, 02 engineering and technology, Tandem mass spectrometry, Biochemistry, Viral protein detection, COVID-19 Testing, Tandem Mass Spectrometry, viral protein detection, nasopharyngeal swab, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Nasopharynx, MESH: Coronavirus Nucleocapsid Proteins, MESH: Betacoronavirus / chemistry, [SDV.MHEP.ME] Life Sciences [q-bio]/Human health and pathology/Emerging diseases, 0303 health sciences, MESH: Pneumonia, Viral* / diagnosis, [SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases, Diagnostic test, Nucleocapsid Proteins, 021001 nanoscience & nanotechnology, 3. Good health, MESH: Tandem Mass Spectrometry / methods, [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Nasopharyngeal swab, Coronavirus Infections, 0210 nano-technology, MESH: Pandemics, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Pneumonia, Viral, Biology, Mass spectrometry, MESH: Phosphoproteins, Article, Virus, Betacoronavirus, 03 medical and health sciences, [SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology, Coronavirus Nucleocapsid Proteins, Humans, [SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology, Pandemics, 030304 developmental biology, Immunodiagnostics, 030102 biochemistry & molecular biology, Clinical Laboratory Techniques, SARS-CoV-2, COVID-19, General Chemistry, Phosphoproteins, Virology, 030104 developmental biology, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Peptides, MESH: Chromatography, Liquid, MESH: Clinical Laboratory Techniques / methods, Chromatography, Liquid

  2. 2

    المساهمون: Ashkenazi, Itamar (ed.)

    المصدر: PLoS ONE
    PLoS ONE, Vol 15, Iss 10, p e0241331 (2020)
    PloS one, vol. 15, no. 10, pp. e0241331

    مصطلحات موضوعية: Viral Diseases, Critical Care and Emergency Medicine, Epidemiology, Cancer Treatment, 030230 surgery, Burden of care, Polymerase Chain Reaction, Health care rationing, Tertiary Care Centers, 0302 clinical medicine, Medical Conditions, Surgical oncology, Neoplasms, Pandemic, Outpatients, Medicine and Health Sciences, Ambulatory Care, 030212 general & internal medicine, Health Workforce, Referral and Consultation, Multidisciplinary, Health Care Rationing, Hospitals, Ambulatory Care/trends, Betacoronavirus/genetics, Coronavirus Infections/epidemiology, Coronavirus Infections/virology, Elective Surgical Procedures/trends, Health Workforce/trends, Hospitalization/trends, Humans, Intensive Care Units, Neoplasms/surgery, Pandemics, Pneumonia, Viral/epidemiology, Pneumonia, Viral/virology, Referral and Consultation/trends, Retrospective Studies, Surgical Oncology/trends, Switzerland/epidemiology, Hospitalization, Infectious Diseases, Surgical Oncology, Oncology, Elective Surgical Procedures, Medicine, Coronavirus Infections, Switzerland, Surgical patients, Research Article, Clinical Oncology, medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), Patients, Science, Pneumonia, Viral, MEDLINE, Surgical and Invasive Medical Procedures, 03 medical and health sciences, Betacoronavirus, medicine, Inpatients, business.industry, SARS-CoV-2, COVID-19, Retrospective cohort study, Covid 19, Health Care, Health Care Facilities, Emergency medicine, Clinical Medicine, business

    وصف الملف: application/pdf

  3. 3

    المساهمون: University of Zurich

    المصدر: Barco, Stefano; Bingisser, Roland; Colucci, Giuseppe; Frenk, André; Gerber, Bernhard; Held, Ulrike; Mach, Francois; Mazzolai, Lucia; Righini, Marc; Rosemann, Thomas; Sebastian, Tim; Spescha, Rebecca; Stortecky, Stefan; Windecker, Stephan; Kucher, Nils (2020). Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial. Trials, 21(1), p. 770. BioMed Central 10.1186/s13063-020-04678-4 <http://dx.doi.org/10.1186/s13063-020-04678-4>
    Trials, vol. 21, no. 1, pp. 770
    Trials, Vol 21, Iss 1, Pp 1-3 (2020)
    Trials

    مصطلحات موضوعية: 11035 Institute of General Practice, medicine.medical_specialty, Acute coronary syndrome, Letter, Randomization, venous thromboembolism, Medicine (miscellaneous), 610 Medicine & health, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Betacoronavirus/pathogenicity, Blood Coagulation/drug effects, Coronavirus Infections/blood, Coronavirus Infections/diagnosis, Coronavirus Infections/drug therapy, Coronavirus Infections/virology, Enoxaparin/administration & dosage, Enoxaparin/adverse effects, Equivalence Trials as Topic, Host-Pathogen Interactions, Humans, Multicenter Studies as Topic, Pandemics, Pneumonia, Viral/blood, Pneumonia, Viral/diagnosis, Pneumonia, Viral/drug therapy, Pneumonia, Viral/virology, Thrombosis/blood, Thrombosis/diagnosis, Thrombosis/prevention & control, Thrombosis/virology, Time Factors, Treatment Outcome, COVID-19, Randomised controlled trial, anticoagulation, elderly, enoxaparin, prevention, protocol, thrombosis, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, Informed consent, law, medicine, Sore throat, Pharmacology (medical), 030212 general & internal medicine, Stroke, COVID, lcsh:R5-920, business.industry, 10031 Clinic for Angiology, 10060 Epidemiology, Biostatistics and Prevention Institute (EBPI), medicine.disease, Comorbidity, Emergency medicine, Ambulatory, medicine.symptom, lcsh:Medicine (General), business, 030217 neurology & neurosurgery

    وصف الملف: application/pdf

  4. 4

    المصدر: Antimicrobial resistance and infection control, 9(1):126
    Antimicrobial resistance and infection control, Vol. 9, No 1 (2020) P. 126
    Antimicrobial Resistance and Infection Control, Vol 9, Iss 1, Pp 1-7 (2020)
    Antimicrobial Resistance and Infection Control

    وصف الملف: application/pdf

  5. 5

    المؤلفون: Ivan Kodvanj, Jan Homolak

    المصدر: International Journal of Antimicrobial Agents

    وصف الملف: application/pdf

  6. 6

    المصدر: European Journal of Cancer
    European Journal of Cancer, Vol. 135 (2020) pp. 130-146
    r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
    instname
    European journal of cancer, vol. 135, pp. 130-146

    مصطلحات موضوعية: 0301 basic medicine, Cancer Research, AROME, Review, Recommendations, Medical Oncology, LMICs, Global Burden of Disease, Pneumonia, Viral/epidemiology/prevention & control/transmission/virology, 0302 clinical medicine, Cancer, COVID-19, Guidelines, Health care, TRONE, Neoplasms, Daily practice, Pandemic, Medicine, Pandemics/prevention & control, Infection Control/economics/organization & administration/standards, Oncology, 030220 oncology & carcinogenesis, Cancer management, Practice Guidelines as Topic, cancer, guidelines, recommendations, health care, Coronavirus Infections, Coronavirus Infections/epidemiology/prevention & control/transmission/virology, medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), Neoplasms/diagnosis/therapy, Pneumonia, Viral, ddc:616.0757, Betacoronavirus/pathogenicity, Betacoronavirus, 03 medical and health sciences, Humans, Developing Countries/economics, Developing Countries, Pandemics, Poverty, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/transmission, Coronavirus Infections/virology, Infection Control/economics, Infection Control/organization & administration, Infection Control/standards, Medical Oncology/economics, Medical Oncology/organization & administration, Medical Oncology/standards, Neoplasms/diagnosis, Neoplasms/therapy, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/transmission, Pneumonia, Viral/virology, Medical Oncology/economics/organization & administration/standards, Infection Control, business.industry, SARS-CoV-2, 030104 developmental biology, Infectious disease (medical specialty), Low and middle income countries, Family medicine, business

    وصف الملف: application/pdf

  7. 7

    المصدر: JCO global oncology, vol. 6, pp. 1248-1257
    JCO Global Oncology

    مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, 2019-20 coronavirus outbreak, Infectious Disease Transmission, Patient-to-Professional, Coronavirus disease 2019 (COVID-19), Clinical Decision-Making, Pneumonia, Viral, MEDLINE, Medical Oncology, Infectious Disease Transmission, Professional-to-Patient, 03 medical and health sciences, Betacoronavirus, 0302 clinical medicine, Clinical decision making, Aged, Betacoronavirus/pathogenicity, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/transmission, Coronavirus Infections/virology, Female, Humans, Infection Control/methods, Infection Control/standards, Infection Control/statistics & numerical data, Infectious Disease Transmission, Patient-to-Professional/prevention & control, Infectious Disease Transmission, Professional-to-Patient/prevention & control, Medical Oncology/methods, Medical Oncology/standards, Medical Oncology/statistics & numerical data, Middle Aged, Neoplasms/diagnosis, Neoplasms/therapy, Oncologists/statistics & numerical data, Pandemics/prevention & control, Personal Protective Equipment/standards, Personal Protective Equipment/statistics & numerical data, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/transmission, Pneumonia, Viral/virology, Practice Patterns, Physicians'/standards, Practice Patterns, Physicians'/statistics & numerical data, Surveys and Questionnaires/statistics & numerical data, Telemedicine/statistics & numerical data, Neoplasms, Surveys and Questionnaires, Health care, Original Reports, medicine, 030212 general & internal medicine, Practice Patterns, Physicians', Pandemics, Personal Protective Equipment, Oncologists, Infection Control, business.industry, Infectious disease transmission, SARS-CoV-2, Cancer, COVID-19, medicine.disease, Telemedicine, Oncology, Neoplasms diagnosis, 030220 oncology & carcinogenesis, Family medicine, business, Coronavirus Infections

    وصف الملف: application/pdf

  8. 8

    المصدر: Microbes and infection, vol. 22, no. 10, pp. 617-621
    Microbes and Infection

    وصف الملف: application/pdf

  9. 9

    المساهمون: Centre de Physiopathologie Toulouse Purpan (CPTP), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Laboratoire de Virologie [Toulouse], CHU Toulouse [Toulouse], Service des maladies infectieuses et tropicales [Toulouse], Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Hôpital Purpan [Toulouse], Gérontopôle de Toulouse, Département de Médecine Interne et Gérontologie Clinique, Centre Hospitalier Universitaire de Toulouse, Epidémiologie et analyses en santé publique : risques, maladies chroniques et handicaps (LEASP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), PINIER, CHRISTINE, Laboratoire Virologie [CHU Toulouse], Institut Fédératif de Biologie (IFB), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Pôle Biologie [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Service Maladies infectieuses et tropicales [CHU Toulouse], Pôle Inflammation, infection, immunologie et loco-moteur [CHU Toulouse] (Pôle I3LM Toulouse), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Pôle Gériatrie [CHU Toulouse]

    المصدر: Journal of Nutrition, Health and Aging
    Journal of Nutrition, Health and Aging, Springer Verlag (Germany), 2020, 24 (7), pp.685-691. ⟨10.1007/s12603-020-1416-2⟩
    The journal of nutrition, health & aging
    Journal of Nutrition, Health & Aging
    Journal of Nutrition, Health & Aging, 2020, 24 (7), pp.685-691. ⟨10.1007/s12603-020-1416-2⟩
    The Journal of Nutrition, Health & Aging

  10. 10